Abstract:Schiff bases are most the widely used class of molecules and their metal complexes are utilized as medicinally important scaffolds due to their versatile biological profile. So herein, we have reported the synthesis of N2O2-type tetradentate Schiff bases {N,N'-(ethylene)bis(salicylideneimine) (1a) and N,N'-(o-phenylene)bis (salicylideneimine) (1b)} and their Ni(II) complexes, dimeric N,N'-(ethylene)bis(salicylideneiminato)nickel(II) (2a) and N,N'-(o-phenylene)bis (salicylideneiminato)nickel(II) (2b), and their characterization by CHN analysis, ESI-MS and XRD techniques. The interaction of the ligands 1a-b and the complexes 2a-b with the biomolecules {calf thymus DNA (CT-DNA) and bovine serum albumin (BSA)} has been investigated by electronic absorption and fluorescence spectroscopy. The results show that the ligands 1a-b and the complexes 2a-b can bind to CT-DNA via a minor groove mode. Moreover, the fluorescence quenching mechanism between the ligands 1a-b and the complexes 2a-b and BSA is a static quenching process. The results showed that the interaction between the ligands 1a-b and BSA is driven by the hydrogen bond and van der Waals interaction while the hydrophobic forces stabilized the interaction between the complexes 2a-b and BSA. Additionally, the r values of the ligands 1a-b and the complexes 2a-b (1a = 0.53 nm, 1b = 0.59 nm, 2a = 0.57 nm and 2b = 0.71 nm) calculated from FRET theory suggested that the distance between the ligands 1a-b and the complexes 2a-b and BSA is quite close. Radical scavenging activity of the ligands 1a-b and the complexes 2a-b was determined in terms of EC50, using the DPPH method. The cytotoxicities of the ligands 1a-b and the complexes 2a-b against human breast cancer (MCF-7) and lung cancer (A549 and H1299) cell lines and healthy lung bronchial (BEAS-2B), breast epithelial (MCF-10A) were investigated. Molecular docking simulations were carried out to correlate the data with the experimental findings. The binding interaction of the ligands 1a-b and the complexes 2a-b with the B-DNA and 1M17 was generated and predicted using Autodock 4.2 software. The results indicated that the ligands 1a-b and the complexes 2a-b bind at the minor groove of DNA through intercalation and at the active side of the EGFR tyrosine kinase.

Novel Nickel(II) complex bearing acenaphthenequinone based thiosemicarbazone bis -Schiff Base: Synthesis, characterization, linkage isomers, antitumor activity, DFT, and DNA docking simulation

Synthesis, Crystal Structure and Cytotoxic Activity of a Novel Nickel（II） Complex with Schiff Base Derived from Salicylhydrazide

Synthesis, Dna/Bsa Binding Studies And In Vitro Biological Assay Of Nickel(Ii) Complexes Incorporating Tridentate Aroylhydrazone And Triphenylphosphine Ligands

Structural and computational analysis of a nickel(II) complex with S -benzyldithiocarbazate Schiff base ligand: Synthesis, X-ray crystallography, MEP, HOMO-LUMO, Hirshfeld surface analysis, and molecular docking

Unsymmetrical Ni(II) Schiff base complex: Synthesis, spectral characterization, crystal structure analysis, Hirshfeld surface investigation, theoretical studies, and antibacterial activity

Structural, theoretical and biological activity of mono and binuclear nickel(II) complexes with symmetrical and asymmetrical 4,6-diacetylresorcinol-dithiocarbazate ligands

Synthesis, Crystal Structure, Hirshfeld Surface Analysis, DNA Binding, DNA Cleavage Activity and Molecular Docking of a New Schiff Base Nickel(ii) Complex

Synthesis, crystal structure and cytotoxic activity of a novel nckel(II) complex with schiff base derived from salicylhydrazide

Structural Design, Anticancer Evaluation, and Molecular Docking of Newly Synthesized Ni(II) Complexes with ONS-Donor Dithiocarbazate Ligands

Synthesis, Crystal Structure and Dna Binding Studies of A Nickel(Ii) Complex with 2-Aminomethylbenzimidazole and Demethylcantharate

Dithiocarbazate ligands and their Ni(II) complexes with potential biological activity: Structural, antitumor and molecular docking study

Structural versatility in nickel (II) complexes of a hydrazone ligand based on alloxan: Preparation, spectroscopic, DFT, anticancer, and molecular docking studies

Synthesis, Crystal Structure and Antitumor Activity of a New Trinuclear Ni(II) Complex Ni-3(C14H8N3O5)(2)(C5H5N)(4)

A Comparative study on the synthesis and crystal structures of Ni(II) complexes bearing tetradentate N2O2 donor Schiff bases: Biomolecular interactions, cytotoxicities and molecular docking

Novel thiosemicarbazone complexes as anticancer agents: Synthesis, characterization, cytotoxicity, docking, and density functional theory studies

Synthesis, crystal structure, Hirshfeld surface analysis and characterization of two new mononuclear Ni(II) complexes.

Six-coordinated nickel (II) complexes with benzothiadiazole Schiff-base ligands: synthesis, crystal structure, magnetic and HFEPR study

A comprehensive study on synthesis and crystal structures of Cu(II) and Ni(II) complexes: In vitro and in silico evaluation of biomolecular interactions, antiproliferative activities and molecular docking

Antitumor and Antibacterial Activity of Ni(II), Cu(II), Ag(I), and Hg(II) Complexes with Ligand Derived from Thiosemicarbazones: Characterization and Theoretical Studies

Molecular docking and biological activities of Ni(II), Cu(II) and Co(II) complexes with a new potentially hexadentate polyamine ligand; X-ray crystal structure of the Cu(II) complex

Synthesis, Structures, and Reactivity of Nickel Complexes Incorporating Sulfonamido-Imine Ligands